Tweet
<img alt="" height="1" width="1" />
ECTRIMS: Cancer Drug Wins in Early MS Trial
MedPage Today
AMSTERDAM -- A low-dose regimen of the leukemia drug alemtuzumab (Lemtrada) slashed annualized relapse rates in patients with newly diagnosed multiple sclerosis in a head-to-head trial against ...
Sanofi says Lemtrada helps MS patients in studyReuters
Sanofi Says Lemtrada Helps More MS Patients Than Rebif in TrialBusinessWeek
Sanofi's Lemtrada Helps MS Patients More Than Rebif In Phase III TrialRTT News
Fox Business -MarketWatch (press release)
all 32 news articles »
More...